New Jersey Attorneys Who Get Results

New Jersey Attorney, New Jersey Medical Malpractice Attorney, NJ Personal Injury Lawyers

Meet Gary Shapiro and David Sternlieb, two experienced New Jersey attorneys who know how to get results. At Shapiro & Sternlieb, we are 100% dedicated to providing our clients with the highest quality legal representation. Through our hard work, persistence and with more than 60 years of combined legal experience, we work hard to protect your rights. As expert lawyers, we have the resources and knowledge to handle complex cases. We pride ourselves on our concern for you as an individual as well as for your legal rights.

Shapiro & Sternlieb: New Jersey Personal Injury Lawyers

auto accident lawyer ,NJ Personal Injury Lawyers, New Jersey Medical Malpractice Attorney

At Shapiro & Sternlieb, your case is our priority. Our attorneys combine outstanding client services with a thorough knowledge of the law and a firm understanding of the latest technology available. Our vast network of legal, medical and professional experts are available to present the best case for you. Located in Manalapan, New Jersey, our lawyers maintain flexible hours to meet your needs. We offer morning, evening or weekend hours, as well as visits to home or hospital, if needed. Our attorneys and staff bring the highest standards of expertise, preparation, concern, diligence, integrity and skill to each case. We take time to return your calls and to ensure each question is answered. You are included every step of the way!

News & Articles


Salmonella Outbreak Linked To Tainted Peanut Butter
CARBON NANOTUBES: A Closer Look at Miracle Technology's Potential Side Effects

Practice Areas

AsbestosInfant & Child Injuries
Auto AccidentsDUI (DWI) Matters
DiscriminationBirth Injuries
Defective ProductsBrain Injury
Burn InjuriesCerebral Palsy
Criminal DefenseClass Action Lawsuits
Construction AccidentsDog Bites
Erbs PalsyFailure To Diagnose Cancer
Gas ExplosionsHead Injury
Juvenile CourtLung Cancer - Mesothelioma
Medical MalpracticeMotorcycle Accidents
NegligenceNegligent Security
Nursing Home AbusePersonal Injury
Premises LiabilitySexual Harassment
Slip & Fall AccidentsTraffic Violations
Truck AccidentsWorkplace Injuries
Wrongful Discharge

FDA Consumer Health Information Updates

http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml

Faster, Easier Cures for Hepatitis C


Mon, 28 Jul 2014 15:34:00 -0400

Advances in drug treatments approved by the Food and Drug Administration (FDA) are giving the 3.2 million Americans with chronic hepatitis C a chance at a longer, healthier life. That's welcome news for baby boomers, a generation that makes up three of four adults with the hepatitis C virus.

FDA Teams Up for Novel Campaign on Risks of Decorative Contact Lenses


Thu, 24 Jul 2014 08:30:00 -0400

The FDA, American Optometric Association and the Entertainment Industries Council are joining forces to launch a campaign for teens and young adults on wearing decorative contact lenses safely. Two videos take clips from American Horror Story to deliver the message.

Juvenile Arthritis: New Discoveries Lead to New Treatments


Mon, 14 Jul 2014 07:00:00 -0400

Juvenile arthritis is one of the most common chronic illnesses affecting children. Learn about new therapies that moderate the effects of the disease.

FDA's MedWatch Safety Alerts: June 2014


Fri, 11 Jul 2014 10:27:00 -0400

FDA warns consumers to avoid topical pain relievers when children are teething; over-the-counter acne treatment that may cause severe hypersensitivity reactions; a weight loss supplement that contains undeclared drugs, and other potential drug-associated hazards.

Consumer Update Analytics


Thu, 03 Jul 2014 11:00:00 -0400

This page contains the most recent Consumer Update data available and links to past Consumer Update Analytics web pages.


Food and Drug Administration--Press Releases

http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/PressReleases/rss.xml

FDA expands approved use of Imbruvica for chronic lymphocytic leukemia


Mon, 28 Jul 2014 12:13:00 -0400

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.

The United States and Mexico sign statement of intent to strengthen produce safety


Thu, 24 Jul 2014 17:32:00 -0400

The U.S. Food and Drug Administration and the government of Mexico’s National Service for Agro-Alimentary Public Health, Safety and Quality (SENASICA) and Federal Commission for the Protection from Sanitary Risks (COFEPRIS) signed a statement of intent forming a partnership to promote the safety of fresh and minimally processed agricultural products.

FDA announces voluntary nationwide recall of all non-expired sterile drugs from Unique Pharmaceuticals


Wed, 23 Jul 2014 14:39:00 -0400

The U.S. Food and Drug Administration is alerting health care professionals and consumers of a voluntary recall of all non-expired drug products produced for sterile use by Unique Pharmaceuticals Ltd., of Temple, Texas.

FDA approves new extended-release oxycodone with abuse-deterrent properties


Wed, 23 Jul 2014 16:29:00 -0400

Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), an extended-release/long-acting (ER/LA) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Targiniq ER is the second ER/LA opioid analgesic with FDA-approved labeling describing the product’s abuse-deterrent properties consistent with the FDA’s 2013 draft guidance for industry, Abuse-Deterrent Opioids – Evaluation and Labeling.

FDA approves Zydelig for three types of blood cancers


Wed, 23 Jul 2014 11:48:00 -0400

The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood cancers.


Recalls RSS

http://www.cpsc.gov/

Metabo Recalls Electric Angle Grinders Due to Laceration Hazard


Thu, 24 Jul 2014 14:30:00 GMT

The grinder's on/off switch can stick in the “On” position, posing a laceration hazard.

Mayborn USA Recalls to Repair Baby Monitors Due to Strangulation Hazard


Thu, 24 Jul 2014 12:00:00 GMT

Child can pull cord into crib and wrap around the neck, posing a strangulation hazard.

Recalled Products Sold by Best Buy and Liquidators After Recall Date


Thu, 24 Jul 2014 10:00:00 GMT

Hazards can include fire, burn, shock, expelled parts, falls and skin irritation depending on the product.

Far East Brokers Recall Glass Beverage Dispenser Set Due to Injury Hazard; Sold Exclusively at Publix


Thu, 24 Jul 2014 02:00:00 GMT

The metal stand supporting the dispenser can break.

Pottery Barn Recalls Bar Stools Due to Fall Hazard (Recall Alert)


Wed, 23 Jul 2014 14:00:00 GMT

The footrest on the Pottery Barn "Donovan" style bar stool can break. This poses a fall hazard to the user.



nnn